Mangalam Drugs Gains 1.38%: 4 Key Factors Driving the Week’s Volatility
2026-11-08 16:00:39Key Events This Week Nov 2: Golden Cross formation signals potential bullish breakout Nov 3: Mojo Score upgraded to Sell from Strong Sell Nov 6: Q2 FY27 results reveal mounting losses despite revenue growth Nov 6: Stock hits lower circuit amid heavy selling pressure Week OpenRs.28.92 Week Close...
Read More
Mangalam Drugs and Organics Ltd Locks at Lower Circuit With 6.66% Loss — Sellers Queue, No Buyers in Sight
2026-11-06 14:00:06At Rs 27.58, sellers were still queuing — but there were no buyers willing to take the other side. Mangalam Drugs and Organics Ltd locked at its lower circuit of 6.66% on 6 Nov 2026, with unfilled sell orders and a frozen price.
Read More
Mangalam Drugs and Organics Ltd Forms Golden Cross Amid Mixed Technical Signals
2026-11-02 18:00:11The 50-day moving average for Mangalam Drugs and Organics Ltd has crossed above the 200-day moving average, creating a golden cross on 2 Nov 2026. Yet, the broader technical indicators and fundamental backdrop present a nuanced picture that tempers the enthusiasm this crossover might otherwise generate.
Read More
Mangalam Drugs and Organics Ltd is Rated Strong Sell
2026-10-28 10:10:25Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 28 October 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Mangalam Drugs and Organics Ltd is Rated Strong Sell
2026-10-16 10:10:25Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 16 October 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.
Read More
Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 1.59% Gain — Buyers Queue, Sellers Absent
2026-10-09 13:00:08At Rs 34.62, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 10% on 09 Oct 2026, with buyers queuing and no sellers willing to part with shares.
Read More
Mangalam Drugs and Organics Ltd is Rated Strong Sell
2026-09-29 10:10:18Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 29 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Mangalam Drugs and Organics Ltd is Rated Strong Sell
2026-09-18 10:10:25Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 10% Gain — Buyers Queue, Sellers Absent
2026-09-10 12:00:08At Rs 34.88, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 10% on 10 Sep 2026, with buyers queuing and no sellers willing to part with shares.
Read MoreBoard Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI LODR 2015
18-Nov-2026 | Source : BSEOutcome of Board Meeting pursuant to Regulation 30 of SEBI LODR 2015 to consider and approve of financial restructuring exploring strategic options and convening of EGM of the Company
Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI LODR 2015
18-Nov-2026 | Source : BSEOutcome of Board Meeting pursuant to Regulation 30 of SEBI LODR 2015 to consider and approve of financial restructuring exploring strategic options and convening of EGM of the Company
Announcement Under Regulation 30 LODR 2015 - Updates
18-Nov-2026 | Source : BSEDisclosure pursuant to Regulation 30 LODR 2025 for approval and consideration by Board of Directors at Meeting held on 18.11.2026 of the Company for undertaking of Financial Restructuring and exploring of various strategic options and convening of EGM to seek members approval to take fesiable action in the aforesaid matter.
Corporate Actions
No Upcoming Board Meetings
Mangalam Drugs and Organics Ltd has declared 5% dividend, ex-date: 21 Dec 17
No Splits history available
No Bonus history available
No Rights history available